Fludarabine, Cyclophosphamide, Mitoxantrone plus Rituximab (FCM-R) in Frontline CLL < 70 Years

Randomized trials demonstrated the superiority of chemoimmunotherapy over chemotherapy in the frontline treatment of CLL. Based on favorable experience with the addition of mitoxantrone (M) to fludarabine (F) plus cyclophosphamide (C), we designed a pilot study testing the combination of FCM plus ri...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Leuk Res
Main Authors: Faderl, Stefan, Wierda, William, O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan, Keating, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4845644/
https://ncbi.nlm.nih.gov/pubmed/19646755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2009.07.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares